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background:  We have already reported that the combined use of optical coherence tomography (OCT) and virtual histology (VH)-IVUS may 
potentially detect thin cap fibroatheroma (TCFA) more accurately than single modality use. The long-term clinical impact of such TCFA identified by 
both modalities is, however, still unknown.
Methods:  A total of 82 non-culprit, angiographicaly mild-to-moderate stenotic plaques in 34 patients were evaluated with OCT and VH-IVUS. IVUS-
derived TCFA was defined as an abundant necrotic core (>10% of the cross-sectional area) in contact with the lumen and %plaque-volume > 40%. 
OCT-derived TCFA was defined as a fibrous cap thickness of < 65 mm overlying a low-intensity area with an unclear border. Plaque meeting both TCFA 
criteria was defined as definite-TCFA (d-TCFA). We divided them into two groups according to the presence or absence of d-TCFA, and compared the 
incidence of clinical events such as cardiac death, non-cardiac death, myocardial infarction, stent thrombosis, target vessel revascularization , target 
lesion revascularization (TLR), and revascularization for de novo lesion between the two groups for a median follow-up duration of 6.5 years. 
results:  Among a total of 82 plaques which underwent both OCT and VH-IVUS evaluation, 15 plaques met the both criteria and categorized as 
d-TCFAs. Among such d-TCFA, 3 plaques required revascularization for an average follow-up of 6.5 years after OCT and IVUS examination, while none 
of non d-TCFA required TLR during the follow-up period. The incidence of TLR in d-TCFA was significantly higher than that in non d-TCFA (20% vs. 0%, 
P=0.005, respectively). Otherwise, there was no statistical difference between patients with and without d-TCFA in clinical events during the follow-up 
period.
conclusions:  The presence of d-TCFA was positively associated with future TLR, suggesting a clinical benefit of combined use of OCT and VH-IVUS 
for the risk stratification of patients with intermediate stenosis.
